✦ LIBER ✦

Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer

✍ Scribed by Jacqueline Vuky; Huong T. Pham; Sarah Warren; Erika Douglass; Kasra Badiozamani; Berit Madsen; Alex Hsi; Guobin Song

Book ID: 118456894
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 248 KB
Volume: 82
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of concurrent weekly docet

Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer

✍ Ronald C. Chen; Julian G. Rosenman; Leroy G. Hoffman; Wing-Keung Chiu; Andrew Z. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Long-term side-effects of intermittent a

Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study

✍ Shawn Malone; Gad Perry; Roanne Segal; Simone Dahrouge; Juanita Crook 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Long-Term Results of a Prospective, Phas

Long-Term Results of a Prospective, Phase II Study of Long-Term Androgen Ablation, Pelvic Radiotherapy, Brachytherapy Boost, and Adjuvant Docetaxel in Patients With High-Risk Prostate Cancer

✍ Steven J. DiBiase; Arif Hussain; Ritesh Kataria; Pradip Amin; Sunakshi Bassi; Na 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Long-term Outcome of a Phase II Trial Co

Long-term Outcome of a Phase II Trial Combining in Situ Gene Therapy and Intensity Modulated Radiotherapy With or Without Hormonal Therapy for Prostate Cancer

✍ B.S. Teh; H. Ishiyama; B. Xu; G. Ayala; T. Wheeler; D. Kadmon; A.C. Paulino; A.I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Analysis of toxicity in patients with hi

Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area

✍ Stefano Arcangeli; Biancamaria Saracino; Maria Grazia Petrongari; Sara Gomellini 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Short- vs long-term androgen suppression

Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate

✍ Anthony V. D'Amico; James W. Denham; Michel Bolla; Laurence Collette; David S. L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## BACKGROUND The study evaluated whether the use of 3 years as compared with 6 months of androgen suppression therapy (AST) combined with external beam radiation therapy (RT) in the treatment of high‐risk prostate cancer was associated with prolonged survival in advanced age men. ##